Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
A study of outpatient participants with Alzheimer's disease or a related dementia who have
difficult behaviors that are upsetting for them or their caregivers. Prazosin is a medication
that is commonly used to treat people with high blood pressure. Research with prazosin has
shown that it may be effective in treating behavioral problems by reducing excess adrenalin
effects in the brain.
Phase:
N/A
Details
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Collaborators:
National Institute on Aging (NIA) VA Puget Sound Health Care System